Stockreport

Global Neutropenia Market Competitive Analysis and Forecast Report to 2028, Featuring BeyondSpring Pharmaceuticals, Coherus Biosciences, Myelo Therapeutics and Spectrum Pharmaceuticals [Ya...

Coherus BioSciences, Inc.  (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com
PDF The Global Neutropenia Market estimated at USD 4.34 Bn in 2023, is expected to reach USD 5.86 Bn by 2028 growing at a CAGR of 6.21%. Neutropenia is a medical disorder [Read more]